The results showed that GAPDH, Bcl-2 and IGFBP6 were amplified from the positive contrasting template [Figure 5C], which confirmed the presence of GAPDH, Bcl-2 and IGFBP6 genes in the total chromatin fraction of pancreatic cancer cells. This evidence concerns the gene BCL2 and pancreatic neoplasm.